• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka
Methicillin-Resistant Staphylococcus Aureus (MRSA): Etiology, At-Risk Populations & Treatment

Methicillin-Resistant Staphylococcus Aureus (MRSA): Etiology, At-Risk Populations & Treatment

9781607413981
2 312,04 zł
2 080,83 zł Zniżka 231,21 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 2 080,83 zł
Ilość
Od 4 do 6 tygodni

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a bacterium responsible for difficult-to-treat infections in humans. It may also be referred to as multidrug-resistant Staphylococcus aureus. MRSA is by definition a strain of Staphylococcus aureus that is resistant to a large group of antibiotics called the beta-lactams, which include the penicillins and the cephalosporins. MRSA was identified as a nosocomial pathogen in the 1960s. MRSA acquisition has traditionally been linked to health care settings and specific patient populations. Established risk factors for MRSA infection include older age, recent hospitalisation or surgery, past antimicrobial therapy, residence in a long-term care facility, dialysis, indwelling percutaneous devices and catheters. This important book gathers the latest research from around the globe in this field and focuses on such topics as:: risk factors for MRSA in a paediatric surgical ward, MRSA treatments, the anatomy of an outbreak, and others.
Szczegóły produktu
72855
9781607413981
9781607413981

Opis

Rok wydania
2010
Numer wydania
1
Oprawa
twarda
Liczba stron
562
Wymiary (mm)
260.00 x 180.00
Waga (g)
1048
  • Preface; The Case for MRSA & Treatment of Methicilllin Resistant Staphylococcus aureus; Therapeutic options for intracellular MRSA:: Current views & perspectives; Methicillin-Resistant Staphylococcus Aureus (MRSA); Hospital & Community-Acquired Methicillin-Resistant Staphylococcus Aureus Bone & Joint Infections; MRSA:: The Virulence, Epidemiology & Perspective Diagnostics & Therapy; Recent Advances in Medicinal Chemistry of New Quinolones with Potential Anti-MRSA Activity; Methicillin-Resistant Staphylococcus aureus:: Etiology, At-Risk Populations & Treatment; Multidrug-Resistant Acinetobacter Baumannii Infections:: Characteristics & Treatment Options; The Anatomy of an Outbreak:: Lessons Learned from an Outbreak of Methicillin-Resistant Staphylococcus aureus Among Newborns & a Review of the Literature; The Emerging & the Re-Emerging of Antimicrobial-Resistant Gram-Positive Cocci:: Evidences Supporting Novel Pharmaceutical Weapons; DHEA-Mediated Phenotypic Alterations in Staphylococcal Cell Wall Architecture; Risk Factors for Carrying Methicillin-Resistant Staphylococcus aureus at Hospitalization in a Pediatric Surgical Ward; Populations At-Risk for Methicillin-Resistant Staphylococcus aureus Infection; Staphylococcus aureus:: Risk Factors for Oronasal Transmission & Dental Aspect; Community-Associated Methicillin-Resistant Staphylococcus aureus:: Etiology, Diagnosis, Prevention & Treatment; Community-Acquired Methicillin-resistant Staphylococcus aureus:: Characterization, Risk Factors, & Treatment; The Changing Pattern of Infections with MRSA & Other Organisms after Major Reconstructive Surgery of the Maxillofacial Region; The Phenomenon of Antibiotic Resistance in an Evolutionary Perspective; Index.
Komentarze (0)